☰

Jeffrey B. VanDeusen, Ph.D. - Publications

Affiliations: 
2004 Ohio State University, Columbus, Columbus, OH 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wesolowski R, Stiff A, Quiroga D, McQuinn C, Li Z, Nitta H, Savardekar H, Benner B, Ramaswamy B, Lustberg M, Layman RM, Macrae E, Kassem M, Williams N, Sardesai S, ... VanDeusen J, et al. Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer. Bmc Cancer. 20: 445. PMID 32429929 DOI: 10.1186/S12885-020-06949-4  0.38
2020 Boutrid H, Kassem M, Tozbikian G, Morgan E, White J, Shah M, Vandeusen J, Sardesai S, Williams N, Stover DG, Lustberg M, Wesolowski R, Pudavalli V, Williams TM, Konda B, et al. TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature. Frontiers in Endocrinology. 11: 228. PMID 32411090 DOI: 10.3389/Fendo.2020.00228  0.3
2020 Adams EJ, Asad S, Reinbolt R, Collier KA, Abdel-Rasoul M, Gillespie S, Chen JL, Cherian MA, Noonan AM, Sardesai S, VanDeusen J, Wesolowski R, Williams N, Shapiro CL, Macrae ER, et al. Metastatic breast cancer patient perceptions of somatic tumor genomic testing. Bmc Cancer. 20: 389. PMID 32375690 DOI: 10.1186/S12885-020-06905-2  0.311
2020 Mousa L, Stephens JA, Berger M, Ramaswamy B, Lustberg M, Sardesai S, Williams N, VanDeusen J, Stover D, Cherian M, Morgan E, Wesolowski R. The impact of granulocyte colony-stimulating factor use in patients with metastatic breast cancer treated with palliative chemotherapy: a single-institution retrospective review. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 32185556 DOI: 10.1007/S00520-020-05392-2  0.317
2020 Morgan E, Suresh A, Ganju A, Stover DG, Wesolowski R, Sardesai S, Noonan A, Reinbolt R, VanDeusen J, Williams N, Cherian MA, Li Z, Young G, Palettas M, Stephens J, et al. Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study. World Journal of Surgical Oncology. 18: 11. PMID 31937323 DOI: 10.1186/S12957-019-1780-8  0.307
2020 Adams EJ, Asad S, Abdel-Rasoul M, Reinbolt RE, Wesolowski R, Tolliver K, Gillespie S, Collier KA, Noonan A, Sardesai S, VanDeusen J, Williams N, Shapiro CL, Macre ER, Ramaswamy B, et al. Abstract P5-10-03: Perceptions of somatic genomic testing in patients with metastatic breast cancer: Psychosocial factors, emotional well-being, and genetic comprehension Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-10-03  0.303
2020 Zhang Y, Nock W, Wyse M, Weber Z, Adams EJ, Sarah A, Stockard S, Tallman D, Singh J, Bae J, Winer EP, Lin NU, Jiang Y, Ma D, Wang P, ... ... VanDeusen J, et al. Abstract P4-05-02: Machine learning predicts rapid relapse in triple negative breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-05-02  0.33
2020 Rinehardt H, Williams N, Morgan E, Kassem M, Palettas M, Miah A, Alnahhas I, Eibl PGP, Suresh A, Puduvalli V, Giglio P, Lustberg M, Wesolowski R, Sardesai S, Stover D, ... VanDeusen J, et al. Abstract P2-20-07: Assessment of leptomeningeal carcinomatosis management and outcomes in patients with advanced breast cancer from 2005 to 2015: A single institution experience Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P2-20-07  0.323
2020 Quiroga DM, Stiff A, McQuinn C, Li Z, Nitta H, Savardekar H, Benner B, Ramaswamy B, Lustberg M, Layman R, Macrae E, Kassem M, Williams N, Sardesai S, VanDeusen J, et al. Abstract 5514: Analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients pre- and post-neoadjuvant chemotherapy for operable breast cancer Immunology. DOI: 10.1158/1538-7445.Am2020-5514  0.373
2020 Cherian M, Datta J, Kassem M, Willingham N, Manouchehri J, David J, Sheth M, Magner A, Mal R, Morgan E, VanDeusen J, Sardesai S, Williams N, Stover D, Lustberg M, et al. Abstract 5158: Estrogen receptor β agonists: A novel therapeutic strategy for breast cancer Cancer Research. 80: 5158-5158. DOI: 10.1158/1538-7445.Am2020-5158  0.374
2019 Boutrid H, Lustberg M, Vandeusen J, Sardesai S, Stover D, Wesolowski R, Cherian M, Stephens J, Palettas M, Morgan E, Kassem M, Berger M, Vargo CA, Ramaswamy B, Williams N. CLO19-027: Assessment of Metastatic Invasive Lobular Carcinoma Management and Outcomes From 2004-2014: A Single Institution Experience Journal of the National Comprehensive Cancer Network. 17: CLO19-027. DOI: 10.6004/Jnccn.2018.7251  0.307
2019 Rinehardt H, Morgan E, Kassem M, Palettas M, Miah A, Alnahhas I, Guillermo Prieto Eibl P, Suresh A, Ganju A, Williams NO, Puduvalli VK, Giglio P, Lustberg MB, Wesolowski R, Sardesai SD, ... ... Vandeusen J, et al. Assessment of Leptomeningeal Carcinomatosis Diagnosis and Outcomes from 2005 to 2015 at Ohio State University. Journal of Clinical Oncology. 37: e13554-e13554. DOI: 10.1200/Jco.2019.37.15_Suppl.E13554  0.313
2019 Sardesai S, Liu J, Palettas M, Stephens J, Stover D, Williams N, Reinbolt R, VanDeusen J, Wesolowski R, Lustberg M, Ramaswamy B. Abstract P4-16-03: Cardiovascular outcomes and long term survival with discontinuation of adjuvant trastuzumab Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-16-03  0.335
2019 Williams N, Liu J, Stephens J, Palettas M, Boutrid H, Sardesai S, Reinbolt R, Stover D, VanDeusen J, Noonan A, Wesolowski R, Lustberg M, Ramaswamy B. Abstract P4-14-12: Outcomes in hormone receptor positive, invasive lobular cancer in the era of endocrine monotherapy Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-14-12  0.306
2019 Zhang Y, Nock W, Asad S, Adams E, Singh J, Damicis A, Lustberg M, Noonan A, Reinbolt R, Sardesai S, VanDeusen J, Wesolowski R, Williams N, Ramaswamy B, Stover D. Abstract P3-07-08: Multi-omic predictor of rapid and late relapse in primary triple negative breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P3-07-08  0.346
2019 Damicis A, Heng Y, Kensler K, Asad S, Adams E, Singh J, Zhang Y, Nock W, Wesolowski R, Williams N, Reinbolt R, Sardesai S, VanDeusen J, Noonan A, Lustberg M, et al. Abstract P1-09-01: CD8+ T-cell gene expression and signatures in breast cancer and adjacent normal breast tissue: Association with body mass index, alcohol intake, and age at diagnosis Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P1-09-01  0.314
2018 Noonan AM, Overcash JA, Suresh A, Flora LK, Stephens J, Bhatt G, Reinbolt R, Williams NO, Wesolowski R, VanDeusen JB, Sardesai SD, Lustberg MB, Ramaswamy B. Abstract A55: A prospective geriatric breast cancer cohort study to define unique features and outcomes in older breast cancer patients Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-A55  0.32
2017 Wing MR, Reeser JW, Smith AM, Reeder M, Martin D, Jewell BM, Datta J, Miya J, Monk JP, Mortazavi A, Otterson GA, Goldberg RM, VanDeusen JB, Cole S, Dittmar K, et al. Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer. Oncotarget. 8: 75822-75833. PMID 29100271 DOI: 10.18632/Oncotarget.20616  0.679
2017 Stiff A, McQuinn C, Wesolowski R, Lustberg MB, Reinbolt RE, VanDeusen JB, Sardesai SD, Williams NO, Noonan AM, Dewani SJ, Ramaswamy B, Carson WE. Effect of neoadjuvant chemotherapy on immune checkpoint expression in breast cancer. Journal of Clinical Oncology. 35: e12126-e12126. DOI: 10.1200/Jco.2017.35.15_Suppl.E12126  0.345
2012 VanDeusen JB, Uronis J, Morse M, Gatza ML, Datto MB, Mantyh C, Lyerly HK, Nevins JR, Clary BM, Hsu SD. Predictive and prognostic markers of recurrence after resection of primary or metastatic colorectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 447. PMID 27983186 DOI: 10.1200/Jco.2012.30.4_Suppl.447  0.302
2010 Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA. In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 184: 2769-75. PMID 20142363 DOI: 10.4049/Jimmunol.0900685  0.769
2010 Yokohama A, Mishra A, Mitsui T, Becknell B, Johns J, Curphey D, Blaser BW, Vandeusen JB, Mao H, Yu J, Caligiuri MA. A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia. Leukemia Research. 34: 203-9. PMID 19660811 DOI: 10.1016/J.Leukres.2009.06.031  0.585
2007 Guimond M, Freud AG, Mao HC, Blaser BW, Lagemann GG, Vandeusen JB, Dorrance A, Ferketich AK, Cavalcanti M, Mackall CL, Caligiuri MA. Mechanism by Which Exogenous Administration of Flt3 Ligand (FL) Expands Natural Killer Cells In Vivo. Blood. 110: 2310-2310. DOI: 10.1182/Blood.V110.11.2310.2310  0.762
2006 VanDeusen JB, Shah MH, Becknell B, Blaser BW, Ferketich AK, Nuovo GJ, Ahmer BM, Durbin J, Caligiuri MA. STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. European Journal of Immunology. 36: 623-30. PMID 16482512 DOI: 10.1002/Eji.200535241  0.592
2003 Farag SS, VanDeusen JB, Fehniger TA, Caligiuri MA. Biology and clinical impact of human natural killer cells. International Journal of Hematology. 78: 7-17. PMID 12894845 DOI: 10.1007/Bf02983234  0.585
2003 VanDeusen JB, Caligiuri MA. New developments in anti-tumor efficacy and malignant transformation of human natural killer cells. Current Opinion in Hematology. 10: 55-9. PMID 12483112 DOI: 10.1097/00062752-200301000-00009  0.541
2002 Cooper MA, Bush JE, Fehniger TA, VanDeusen JB, Waite RE, Liu Y, Aguila HL, Caligiuri MA. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood. 100: 3633-8. PMID 12393617 DOI: 10.1182/Blood-2001-12-0293  0.745
2001 Fehniger TA, Suzuki K, VanDeusen JB, Cooper MA, Freud AG, Caligiuri MA. Fatal leukemia in interleukin-15 transgenic mice. Blood Cells, Molecules & Diseases. 27: 223-30. PMID 11358383 DOI: 10.1006/Bcmd.2001.0379  0.757
2001 Fehniger TA, Suzuki K, Ponnappan A, VanDeusen JB, Cooper MA, Florea SM, Freud AG, Robinson ML, Durbin J, Caligiuri MA. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. The Journal of Experimental Medicine. 193: 219-31. PMID 11208862 DOI: 10.1084/Jem.193.2.219  0.761
2000 Fehniger TA, Bluman EM, Porter MM, Mrózek E, Cooper MA, VanDeusen JB, Frankel SR, Stock W, Caligiuri MA. Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. The Journal of Clinical Investigation. 106: 117-24. PMID 10880055 DOI: 10.1172/Jci6218  0.737
1999 Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. Journal of Immunology (Baltimore, Md. : 1950). 162: 4511-20. PMID 10201989  0.722
Show low-probability matches.